These data suggest that a functional regulatory variant alters the binding affinity of a key transcription factor, PU.1, and disruption of this locus impacts EIF3A expression and vincristine sensitivity in ALL cells. The gene discussed is EIF3A; the disease is acute lymphoblastic leukemia.